**Core Concept**
Cyclosporine is an immunosuppressive medication used to treat nephrotic syndrome, a condition characterized by excessive loss of protein in the urine. The underlying mechanism involves the inhibition of T-lymphocyte activation, which plays a crucial role in the pathogenesis of nephrotic syndrome.

**Why the Correct Answer is Right**
Cyclosporine acts by inhibiting calcineurin, a phosphatase enzyme that dephosphorylates and activates Nuclear Factor of Activated T-cells (NFAT), a transcription factor essential for T-lymphocyte activation. By inhibiting calcineurin, cyclosporine prevents the transcription of genes involved in the immune response, thereby reducing the inflammation and proteinuria associated with nephrotic syndrome.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because cyclosporine does not act by inhibiting the renin-angiotensin-aldosterone system (RAAS), which is a different mechanism of action for other classes of medications, such as ACE inhibitors and ARBs.

**Option B:** This option is incorrect because cyclosporine does not primarily act by reducing the production of inflammatory cytokines, although it may have some anti-inflammatory effects as a secondary mechanism.

**Option C:** This option is incorrect because cyclosporine does not act by increasing the synthesis of prostaglandins, which is a mechanism of action for nonsteroidal anti-inflammatory drugs (NSAIDs).

**Clinical Pearl / High-Yield Fact**
Cyclosporine is a calcineurin inhibitor that has a narrow therapeutic index, requiring careful monitoring of blood levels to avoid nephrotoxicity and other adverse effects.

**Correct Answer:** D. Inhibiting calcineurin